is the only epinephrine nasal spray used for the emergency treatment of allergic reactions, including anaphylaxis in adults and children 4 years and older who weigh 33 lbs. or greater. is right for ...

In a pivotal development this year, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) in August 2024 for emergency use in type 1 allergic reactions, such as anaphylaxis.

The U.S. Food and Drug Administration has approved ARS Pharmaceuticals' nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions. REUTERS The U.S. Food and ...

FAYETTEVILLE, N.Y. (WSYR-TV) — As allergy season picks up, doctors are reminding families about a newer option for treating life-threatening allergic reactions. With one quick spray, doctors say Neffy ...

Results suggest real-world effectiveness of neffy is consistent with that historically reported for epinephrine injection Figure 1: Treatment success rate with a single dose of neffy administered by a ...

FDA approves Neffy 1 mg for children aged 4+ weighing 15 to <30 kg for allergic reactions. Most insured patients can access Neffy for $25, while cash price is $199 for two doses. Get our list of 10 ...

neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...